Skip to main content
OpenTrials
Completed

NCT Number: NCT01371513

Korean Practice Patterns for Screening PCA(Prostate Cancer)

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008

Exclusion criteria

  • Age less than 40 at PSA screening
  • History of drug use which can affect level of PSA within 6months before PSA screening
  • Subject who participate any other clinical trial

Treatment and study plan

continuous screening

Other

practice patterns for screening prostate cancer

Primary outcomes

  1. Number of subjects with prostate biopsy

    Time frame: 1year

Secondary outcomes

  1. Number of subjects with prostate cancer

    Time frame: 1year

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level

Acronym: RESPECT

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 10, 2011
Registry last updated
May 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.